Telehealth for opioid use disorder in vulnerable settings
Part of Mental health clinical trials.
This trial tests whether a telehealth program can help people with opioid use disorder get and stay on buprenorphine treatment. It aims to make care more accessible for those in vulnerable situations.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a history of opioid use disorder.
- You are starting buprenorphine treatment now, or have started it within the past 45 days.
- You speak and understand English.
- You are not allergic to buprenorphine.
- You plan to stay in a Boulder Care-affiliated state for the next 12 months.
- You do not have any untreated mental or medical condition that would keep you from taking part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a tailored telehealth program can help people with opioid use disorder get better access to treatment. It is designed for patients who are already receiving or starting treatment with buprenorphine at Prevention Point Philadelphia.
This trial tests whether taking buprenorphine (a medicine for opioid use disorder) through telemedicine works as well as standard in-person care. You may be enrolled if you’re seeking treatment for opioid use disorder and can safely follow study steps.
This study tests whether treatment for opioid use disorder can be done effectively through telehealth (video calls and texts). It is designed for people who are not currently on medication for opioid addiction and want to start treatment from home.
This study compares follow-up care after an emergency department visit for opioid addiction: either through telehealth (video visits) or in-person appointments. The goal is to see which method helps people stay in treatment after they leave the ED.
This trial tests whether a program that combines medication (buprenorphine) with extra support can help people who have had an opioid overdose avoid future overdoses. If you have been seen at UAB Hospital for an opioid overdose, you may be able to join.
This study tests a behavioral support program designed to help people newly starting buprenorphine treatment for opioid use disorder stay engaged with their care. If you've recently started buprenorphine or just been released from incarceration and are beginning treatment, this trial may help you maintain consistent medication use and reduce the risk of relapse.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.